HR 9190
  • Introduced
    Jun 08, 2026
  • Passed House
  • Passed Senate
  • Became Law
HR 9190
United States House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
To amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.
Last Action See all actions
House • Jun 08, 2026: Referred to the House Committee on Energy and Commerce.

Summary

Comments on HR 9190

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • Jun 08, 2026 | House
    • Introduced in House
    • Referred to the House Committee on Energy and Commerce.
Bill Texts
Looks like there aren't any bill texts available at this moment.
Documents
Looks like we don't have any documents available at this moment.
Sources